Indexed from the September 24 newsletter. Linked-source claims have not been independently verified.
Development
An analysis identifies disease-mechanism selection as a bottleneck
Faster discovery does not by itself resolve uncertainty about therapeutic targets.
Claim
The newsletter cites an analysis arguing that selecting the right disease mechanism remains a major constraint in AI drug discovery.
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to September 24, 2026 (theinnermostloop.substack.com)
- Source linked by the September 24 issue (www.mckinsey.com)
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.